Lv71
4580 积分 2023-06-19 加入
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
11天前
已完结
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
15天前
已完结
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
15天前
已关闭
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study
19天前
已完结
Systematic Review of Neoadjuvant Immunotherapy for Mismatch Repair Deficient Locally Advanced Colon Cancer: An Emerging Strategy
19天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
19天前
已完结
Nonoperative Management of Mismatch Repair–Deficient Tumors
19天前
已完结
The Landscape of Medical AI in China
1个月前
已完结
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
3个月前
已完结
皖公网安备34019202002308
